Los Angeles : 09:00 AM - 10:00 AM
Aug 18 • 12:00 PM - 01:00 PM
Aug 18 • 05:00 PM - 06:00 PM
Aug 18 • 06:00 PM - 07:00 PM
Aug 18 • 09:30 PM - 10:30 PM
Aug 19 • 12:00 AM - 01:00 AM
Aug 19 • 02:00 AM - 03:00 AM
Supported by an Open Unrestricted Educational Grant
There is no cost to register for this activity.
The Application of LC-MS Fueling the Next Phase of Precision Medicine
Jennifer Van Eyk, PhD
Cedars-Sinai Heart Institute
Jennifer Van Eyk, PhD, is an international leader in the area of clinical proteomics and her lab has focused on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. This includes multiple reaction monitoring (MRM, also known as SRM) and most recently data independent acquisition. Dr. Van Eyk's laboratory is well known for the extreme technical quality of the data generated, rigorous quality control with tight %CV while applying these to key clinical questions. The aim is to maximize throughput and reproducibility in order to move targeted and robust discovery methods into large population healthy continuous assessment and clinical grade assays focusing on brain and cardiovascular diseases.
The throughput and reproducibility of LC-MS has facilitated the development of biologically important protein assays that are facilitating precision medicine adoption.